Synergistic Ocular Delivery Systems with AI, IoT, and Blockchain Integration

The present invention combines the ocular delivery systems and methods of the original patent with advanced technologies like AI, IoT, and blockchain to create a more effective, personalized, and data-driven treatment approach for ocular conditions.

The original patent disclosed ocular delivery systems and methods for accessing Schlemm's canal, delivering viscoelastic fluids, and performing trabeculotomies. However, these systems lacked the ability to analyze patient-specific data, optimize treatment parameters, and integrate with wearable technology and cloud-based servers. The present invention addresses these limitations by incorporating synergistic combinations of AI, IoT, blockchain, and MEMS technologies to enhance ocular treatment outcomes.

The inventive concept comprises a fluid delivery system with an AI module that analyzes eye anatomy and optimizes fluid delivery parameters. Additionally, a blockchain-based data management system tracks and analyzes patient treatment data, enabling personalized adjustments to the fluid composition. An IoT-enabled sensor monitors intraocular pressure, and a MEMS-based actuator provides precision control of the trabeculotomy procedure. The system also includes a machine learning algorithm for predicting optimal treatment parameters based on patient-specific eye anatomy and treatment history, and a 3D printed custom implant for delivering the viscoelastic fluid composition to Schlemm's canal. Furthermore, the system integrates with wearable technology to monitor intraocular pressure and receive personalized treatment recommendations.

The present invention's novelty lies in the synergistic integration of AI, IoT, blockchain, and MEMS technologies with the original ocular delivery systems and methods. The inventive step resides in the unexpected combination of these technologies to create a more effective, personalized, and data-driven treatment approach for ocular conditions.

Alternative embodiments of the inventive concept may include the use of other AI algorithms, different IoT sensors, or alternative blockchain architectures. Additionally, the system could be adapted for use in other medical applications, such as cardiovascular or neurological treatments.

The present invention has significant commercial potential in the ophthalmology market, particularly in the treatment of glaucoma and other ocular conditions. The integration of AI, IoT, and blockchain technologies is expected to increase treatment efficacy, reduce costs, and improve patient outcomes. The market for ocular delivery systems is projected to grow significantly in the coming years, driven by the increasing prevalence of ocular diseases and the need for more effective treatment options.